B6RLX2 AF NFT

Kunitz-type serine protease inhibitor TCI

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeidwuvnx63aedscai7k7wpnfj6ypowo3xcc4tmans6efvjpg7qturm/metadata.json
IPFS of structure file: 
bafybeid4lffpqxpnzablvj6wfo5an56uqte4ux22mkonnj237cypfvd7iq/AF-B6RLX2-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x83F786ce01f5479fe16b8Cc8921aa2b71C99D1C9
First NFT owner address (bech32): 
genesis1s0mcdnsp74relctt3nyfyx4zkuwfn5wfl45cr6
Current NFT ID #496949 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
496949
Accession (UniProt):
B6RLX2
Name::
Kunitz-type serine protease inhibitor TCI
Experimental Method:
Predicted structure
Sequence source:
OPHIOPHAGUS HANNAH

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B6RLX2 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B6RLX2|VKTCT_OPHHA Kunitz-type serine protease inhibitor TCI OS=Ophiophagus hannah OX=8665 PE=1 SV=1 MSSGRLLLLLGLLTLWAELTPVSGLGRPKFCELPAVSGFCKAYIPSFYYNPDASACQKFIYGGCGGNANKFKTIEECHRTCVG